Start Vaccinating News Today

India to start vaccinating 12 to 14-year-olds against COVID-19

So these are some early clues and they -- they have to see how this continues to -- if that data continues to hold up. one thing i think is interesting, anderson, if you look at the trajectory in south africa over the past few variants and sort of look what has happened. the original variant, and then beta, delta, you see sort of this interesting -- you know, these interesting peaks. i dont know if we have the graphic, we can put it up. but basically, you see a significant surge and then a perio...

This continues to -- if that data continues to hold up. one thing i think is interesting, anderson, if you look at the trajectory in south africa over the past few variants and sort of look what has happened. the original variant, and then beta, delta, you see sort of this interesting -- you know, these interesting peaks. i dont know if we have the graphic, we can put it up. but basically, you see a significant surge and then a period of quieting. and then, another significant surge. keep in min...

Singapore to Start Vaccinating 12-18 Year-old Adolescents as PM Outlines Reopening Plans News18 2 hours ago © Provided by News18 Singapore to Start Vaccinating 12-18 Year-old Adolescents as PM Outlines Reopening Plans Singapore is opening up its Covid-19 vaccination programme to adolescents from Tuesday to help contain the latest outbreak that has infected some students, and will step up testing and tracing. The city-state is among the first countries in the world to offer vaccines to teen...

The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.

The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.

France Halts Brazil Flights; NYC Reschedules Shots: Virus Update Bloomberg 17 mins ago Bloomberg News (Bloomberg) -- The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe. German Chancellor Angela Merkel’s cabinet approved a law setting nationwide rules on virus restrictions after some regions failed to...

The U.S. expects to have enough vaccine to meet demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.

U.S. President Joe Biden said the U.S. may have enough vaccine for every adult American by the end of May as Merck & Co. Inc. confirmed it will help make rival Johnson & Johnson’s shot. He said he hopes the nation can return to normal a year from now.

U.S. President Joe Biden said the U.S. may have enough vaccine for every adult American by the end of May as Merck & Co. Inc. confirmed it will help make rival Johnson & Johnson’s shot. He said he hopes the nation can return to normal a year from now.